Biogen (NASDAQ:BIIB) is preparing to release its quarterly earnings on Friday, 2026-02-06. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Biogen to report an earnings per share (EPS) of $1.62.
Anticipation surrounds Biogen’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Earnings History Snapshot
During the last quarter, the company reported an EPS beat by $0.92, leading to a 3.11% increase in the share price on the subsequent day.
Here’s a look at Biogen’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 3.89 | 3.91 | 2.52 | 3.35 |
| EPS Actual | 4.81 | 5.47 | 3.02 | 3.44 |
| Price Change % | 3.00 | 3.00 | 2.00 | 4.00 |
Tracking Biogen’s Stock Performance
Shares of Biogen were trading at $185.45 as of February 04. Over the last 52-week period, shares are up 31.2%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analysts’ Perspectives on Biogen
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Biogen.
Biogen has received a total of 9 ratings from analysts, with …